E-viri
PDF
Recenzirano
Odprti dostop
-
Velazquez, Eric J; Morrow, David A; DeVore, Adam D; Duffy, Carol I; Ambrosy, Andrew P; McCague, Kevin; Rocha, Ricardo; Braunwald, Eugene
The New England journal of medicine, 02/2019, Letnik: 380, Številka: 6Journal Article
Patients with acute decompensated heart failure were randomly assigned to receive sacubitril–valsartan or enalapril. At 8 weeks, the sacubitril–valsartan group had a greater reduction in the N-terminal pro–B-type natriuretic peptide concentration than the enalapril group.
